Azucena Salazar-Piña

Prof. Azucena Salazar-Piña

Universidad Autónoma del Estado de Morelos

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2021 in Plants
Verified
Journal Article
Open access
PDF file
PAPablo F. Aparicio-García
Pablo F. Aparicio-García
RARosa Isela VENTURA AGUILAR
Rosa Isela VENTURA AGUILAR
Juan Carlos Del Río GarcíaJuan Carlos Del Río García
Juan Carlos Del Río García
MHMónica Hernández-López
Mónica Hernández-López
DSDAGOBERTO SANCHEZ
DAGOBERTO SANCHEZ
Silvia Bautista-BañosSilvia Bautista-Baños
Silvia Bautista-Baños
Biodegradable alternatives for the control of Aspergillus flavus in fig fruit were tested with the application of coatings based on chitosan (CS) and propolis (P). To potentiate the fungicidal effect, nanoparticles of these two (CSNPs and PNPs) were also considered. The objectives of this research were to evaluate the effect of different formulations on: (a) the ripening process of the fig, (b) the incidence of A. flavus and the production of aflatoxins, and (c) the acceptance of the treated fruit by a panel. The nanostructured coatings did not influence the ripening process of the fruit during the 12 days of storage, however, the antioxidant activity increased by approximately 30% with the coating CS + PNPs + P. The figs treated with CS + CSNPs + PNPs + P, inhibited the growth of the fungus by about 20% to 30% under laboratory and semi-commercial conditions. For all treatments, the aflatoxin production was lower than 20 ppb compared to the control with values of c.a. 250 ppb. The sensory quality was acceptable among the panel. The edible coatings can be a non-toxic alternative for post-harvest preservation and the consumption of fig fruit. The next step will be its inclusion and evaluation at a commercial level in packing houses.

1 February 2021 in Molecular Cancer Research
Verified
Journal Article
Closed access
PDF file
LGLourdes Gutierrez-Xicotencatl
Lourdes Gutierrez-Xicotencatl
APAdolfo Pedroza-Saavedra
Adolfo Pedroza-Saavedra
LALilia Chihu Amparan
Lilia Chihu Amparan
ASAzucena Salazar-Piña
Azucena Salazar-Piña
MMMinerva Maldonado-Gama
Minerva Maldonado-Gama
FEFERNANDO ESQUIVEL
FERNANDO ESQUIVEL
The human papillomavirus (HPV) is recognized as the main etiologic agent associated with cervical cancer. HPVs are epitheliotropic, and the ones that infect the mucous membranes are classified into low-risk (LR) and high-risk (HR) types. LR-HPVs produce benign lesions, whereas HR-HPVs produce lesions that may progress to cancer. HR-HPV types 16 and 18 are the most frequently found in cervical cancer worldwide. E6 and E7 are the major HPV oncogenic proteins, and they have been profusely studied. Moreover, it has been shown that the HPV16 E5 (16E5) oncoprotein generates transformation, although the molecular mechanisms through which it carries out its activity have not been well defined. In contrast to E6 and E7, the E5 open reading frame is lost during the integration of the episomal HPV DNA into the cellular genome. This suggests that E5 acts at the early stages of the transformation process. In this review, we focused on the biochemical characteristics and functions of the HPV E5 oncoprotein, mainly on its association with growth factor receptors and other cellular proteins. Knowledge of the HPV E5 biology is important to understand the role of this oncoprotein in maintaining the viral cycle through the modulation of proliferation, differentiation, and apoptosis, as well as the alteration of other processes, such as survival, adhesion, migration, and invasion during early carcinogenesis. Finally, we summarized recent research that uses the E5 oncoprotein as a therapeutic target, promising a novel approach to the treatment of cervical cancer in its early stages.

23 November 2021 in Plants
Verified
Journal Article
Open access
PDF file
MSMario Alberto Segura-Palacios
Mario Alberto Segura-Palacios
ZCZormy Correa
Zormy Correa
MCMaria Luisa Corona-Rangel
Maria Luisa Corona-Rangel
OMOllin Celeste Martinez-Ramirez
Ollin Celeste Martinez-Ramirez
ASAzucena Salazar-Piña
Azucena Salazar-Piña
Silvia Bautista-BañosSilvia Bautista-Baños
Silvia Bautista-Baños
Aspergillus flavus affects fresh and dry fruit and vegetable products, and its toxic metabolites, namely aflatoxins, cause serious damage in humans. The objective of this research study was to evaluate the effect of commercial natural products as well as edible and nanostructured chitosan coatings on the development of A. flavus and on the production of aflatoxins in vitro and in tomato. Treatments were as follows: chitosan 1%, chitosan coating, chitosan nanostructured coating, Citrocover 1% (citrus seed extract), Resinadher 0.5% (pine resin extract), mancozeb 2%, and water. The variables were as follows: halo inhibition, spore production, and aflatoxins content. In fruit, the following were evaluated: disease incidence, mycelial growth, and aflatoxin production. An ANOVA (Tukey: p < 0.05) was used. In vitro results showed that Citrocover and Resinadher reduced sporulation (0.2 and 0.9 × 105 spores mL−1, respectively), while chitosan inhibited the production of aflatoxins. With Resinadher and Citrocover, tomato fruit had the lowest incidence, mycelial growth, and aflatoxin production with corresponding values of 0%, 0.0 cm2, and 0.95 ppb, respectively, and 7%, 0.2 cm2, and 1.77 ppb, respectively. The use of Citrocover and Resinadher could be a viable alternative to decrease the development of A. flavus in tomato fruit.

6 December 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
CMCeleste Martinez
Celeste Martinez
ASAzucena Salazar-Piña
Azucena Salazar-Piña
XCXimena Cerón-Ramírez
Ximena Cerón-Ramírez
JRJulieta Rubio-Lightbourn
Julieta Rubio-Lightbourn
FTFernando Torres-Romero
Fernando Torres-Romero
CCCLEMENTINA CASTRO-HERNANDEZ
CLEMENTINA CASTRO-HERNANDEZ
Background and Aims: Currently, treatments are being sought to improve the control of type II diabetes mellitus (T2DM), and inulin has been shown to be effective in reducing glucose levels and other metabolic control parameters. These effects on metabolic control may be associated with changes in the epigenetic modulation of genes of the insulin pathway. Therefore, our objective is to determine the effect of agave inulin in metabolic control parameters and in INS and IRS1 genes’ methylation in T2DM patients. Methods: This was a longitudinal experimental study with 67 Mexican participants who received an intervention of inulin agave (10 g daily) for 2 months. The methylation of the INS and IRS1 genes was determined by MSP. Results: For the INS gene, we found a significant decrease in the proportions of T2DM patients with methylated DNA after inulin intervention (p = 0.0001). In contrast, the difference in the proportions of the unmethylated IRS1 gene before and after the inulin intervention was not significant (p = 0.79). On the other hand, we observed changes in the number of T2DM patients’ recommended categories for metabolic control depending on the methylation of INS and IRS1 genes before and after treatment with inulin. Conclusion: For the first time, we report the modification in the methylation of two genes, INS and IRS1, of the insulin pathway and provide information on the possible relevant role of epigenetics as a key factor in positive changes in metabolic control parameters by inulin intake in T2DM patients.

AAAlexis Alonso-Bastida
Alexis Alonso-Bastida
MMManuel Adam Medina
Manuel Adam Medina
RPRuben Posada
Ruben Posada
ASAzucena Salazar-Piña
Azucena Salazar-Piña
GLORIA LILIA OSORIO GORDILLOGLORIA LILIA OSORIO GORDILLO
GLORIA LILIA OSORIO GORDILLO
LVLuis Gerardo Vela-Valdés
Luis Gerardo Vela-Valdés
This work presents a mathematical model of homeostasis dynamics in healthy individuals, focusing on the generation of conductive data on glucose homeostasis throughout the day under dietary and physical activity factors. Two case studies on glucose dynamics for populations under conditions of physical activity and sedentary lifestyle were developed. For this purpose, two types of virtual populations were generated, the first population was developed according to the data of a total of 89 physical persons between 20 and 75 years old and the second was developed using the Monte Carlo approach, obtaining a total of 200 virtual patients. In both populations, each participant was classified as an active or sedentary person depending on the physical activity performed. The results obtained demonstrate the capacity of virtual populations in the generation of in-silico approximations similar to those obtained from in-vivo studies. Obtaining information that is only achievable through specific in-vivo experiments. Being a tool that generates information for the approach of alternatives in the prevention of the development of type 2 Diabetes.

2 May 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
ASAdolfo Pedroza Saavedra
Adolfo Pedroza Saavedra
ARAngelica Nallelhy Rodriguez-Ocampo
Angelica Nallelhy Rodriguez-Ocampo
ASAzucena Salazar-Piña
Azucena Salazar-Piña
APAislinn Citlali Perez-Morales
Aislinn Citlali Perez-Morales
LALilia Chihu Amparan
Lilia Chihu Amparan
LGLourdes Gutierrez-Xicotencatl
Lourdes Gutierrez-Xicotencatl
Antibodies against the Human Papillomavirus (HPV) L1 protein are associated with past infections and related to the evolution of the disease, whereas antibodies against L1 Virus-Like Particles (VLPs) are used to follow the neutralizing antibody response in vaccinated women. In this study, serum antibodies against conformational (VLPs) and linear epitopes of HPV16/18 L1 protein were assessed to distinguish HPV-vaccinated women from those naturally infected or those with uterine cervical lesions. The VLPs-16/18 were generated in baculovirus, and L1 proteins were obtained from denatured VLPs. Serum antibodies against VLPs and L1 proteins were evaluated by ELISA. The ELISA-VLPs and ELISA-L1 16/18 assays were validated with a vaccinated women group by ROC analysis and the regression analysis to distinguish the different populations of female patients. The anti-VLPs-16/18 and anti-L1-16/18 antibodies effectively detect vaccinated women (AUC = 1.0/0.79, and 0.94/0.84, respectively). The regression analysis showed that anti-VLPs-16/18 and anti-L1-16/18 antibodies were associated with the vaccinated group (OR = 2.11 × 108/16.50 and 536.0/49.2, respectively). However, only the anti-L1-16 antibodies were associated with the high-grade lesions and cervical cancer (CIN3/CC) group (OR = 12.18). In conclusion, our results suggest that anti-VLPs-16/18 antibodies are effective and type-specific to detect HPV-vaccinated women, but anti-L1-16 antibodies better differentiate the CIN3/CC group. However, a larger population study is needed to validate these results.